Skip to main content

Table 2 Intraoperative data (ITT analysis)

From: Goal-directed fluid therapy using uncalibrated pulse contour analysis and balanced crystalloid solutions during hip revision arthroplasty: a quality implementation project

 

Crystalloid group (n = 66)

Colloid group (n = 130)

Control group (n = 130)

p

Anesthesia time (min)

188 (145–250)

197 (170–254)

185 (160–230)

0.168a

Surgery time (min)

119 (84–162)

135 (107–171)

125 (99–159)

0.063a

Cumulative amount of infused volume (ml)

2575

(2000–4210)

2435

(1760–3480)

2210

(1658–3000)

0.063a

Crystalloids (ml)

2250

(1750–3000)

725

(500–1000)

1500

(1000–2000)

 < 0.001a

Colloids (ml)

0

(0–0)

1250

(1000–1750)

500

(500–1000)

 < 0.001a

Median SV (ml)

65 (54–74)

67.5 (60–75.25)

-

0.96c

Inotropes (%)

19 (28.8%)

28 (21.5%)

18 (13.8%)

 < 0.001b

Blood transfusion (%)

18 (27.3%)

57 (43.8%)

47 (36.2%)

0.071b

Intraoperative blood loss (ml)

800

(475–1200)

1000

(500–1500)

800

(485–1500)

0.562a

Necessity NE

25 (37.9%)

20 (25.4%)

31 (40.3%)

0.002

Average max. NE-dose (µg/kg Bodyweight/min)

0.027

0.0133

0.0191

0.004a

NE at end of surgery

10 (15.2%)

10 (7.7%)

18 (13.8%)

0.185b

Postoperative admission to

0.223b

 Recovery room

45 (68.2%)

71 (54.6%)

75 (57.7%)

 PACU

18 (27.3%)

53 (40.8%)

44 (33.8%)

 ICU

3 (4.5%)

6 (4.6%)

11 (8.5%)

LOS

 Recovery room (min)

150 (115.5–190)

160 (110–205)

170 (120–240)

0.177a

 PACU/ICU (min)

750 (427.5–1235)

400 (207–825)

960 (360–1210)

 < 0.001a

  1. Parameters are shown as median with 25th and 75th percentile or absolute and relative frequencies (indicated by a percentage sign)
  2. NE Norepinephrine, PACU Post-anesthesia care unit
  3. All p values constitute exploratory analysis comparing overall differences between all three groups: aKruskal–Wallis test, bchi-square test, CMann–Whitney U test